MSB 2.51% 97.0¢ mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-102

  1. 16,918 Posts.
    lightbulb Created with Sketch. 2406
    Yes there would definitely be a conflict of interest.
    If you recall Surgcentre now have at least director now as part of the deal with undisclosed details to help organise a cap raise.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.025(2.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
99.0¢ $1.03 97.0¢ $2.815M 2.838M

Buyers (Bids)

No. Vol. Price($)
9 151781 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 80522 1
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.